- 4 hrs ago Erythritol: Health Benefits And Side Effects
- 4 hrs ago International Men's Day 2019: Things You Can Do To Make Your Man Feel Special
- 5 hrs ago This Winter Season, Keep Your Nail Game Strong With These Superb Trending Colours
- 6 hrs ago Aamir Khan's Laal Singh Chaddha Look Is So In Tune With The Fashion Sensibilities Of A Common Man
- Sports India vs Bangladesh: Indian team on a roll, but ‘no days off’ for skipper Virat Kohli - Watch
- News Vodafone Idea, Airtel to raise mobile service rates from December amid financial crunch
- Technology Redmi Note 8 With 3GB RAM To Be Launched Soon In India: Price And Availability
- Movies Rakul Preet Singh Joins The Cast Of John Abraham And Jacqueline Fernandez Starrer Attack
- Finance Should You Get An Insurance To Cover Possible Loss Of Car Keys?
- Automobiles Land Rover Off-Road Driving Experience: The "Above & Beyond Tour 2019’ Comes To Bangalore
- Travel Igatpuri – A Perfect Travel Destination
- Education JEE Main 2020 Sample Question Paper With Solution For Numerical Value Section
A recent study published in the Journal of Clinical Investigation asserted that a new potential medication has the ability to suppress an HIV infection. The medication works within an HIV-infected person's own body to suppress the virus, which cannot be treated using the available HIV treatments as most treatment methods fail to combat them  .
The study also points out that the potential new drug is capable of complementing the existing HIV antiretroviral therapy (ART) medications. Apart from that, there is also a possibility suggesting that the newly discovered drug can cause HIV remission without a lifetime of ART medication consumption.
As the human immunodeficiency virus gets attached to the HIV infected individual's genetic coding, it causes a constant dormant infection which inherently results in the development of complications in treatment. It is due to this integration the ART medications fail to treat the condition. Consequently, once the ART medications are stopped by the HIV affected individual, the virus multiplies and causes elevated levels of complications within the body   .
The head researcher Haitao Hu asserted that "We are the first to show that human BRD4 protein and its associated machinery can be harnessed to suppress dormant HIV. Our findings are exciting because they not only improve our understanding of the biology of HIV epigenetic regulation, they also present a promising approach for the development of probes and therapeutic agents for HIV silencing, hopefully leading to cure of the virus eventually."
The researchers also pointed out that the protein BRD4 plays a central role in regulating the production of new copies of the HIV gene. A series of small molecules were designed, synthesized and evaluated by the team with the purpose of programming BRD4 to suppress HIV, which helped in the identification of a lead compound called ZL0580. This lead compound was then tested in HIV infection models, cultivating the result that the compounds possess the ability to delay dormant HIV reactivation  .
Jia Zhou, co-senior researcher asserted that "We will continue to optimize the chemical structure and effectiveness of this class of molecules and conduct safety testing in cellular and animal studies."
The researchers are looking forward to beginning the clinical trials so that the medication used in the treatment of HIV-infected individuals.
-  Niu, Q., Liu, Z., Alamer, E., Fan, X., Chen, H., Endsley, J., ... & Robb, M. L. (2019). Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV. The Journal of clinical investigation, 129(8).
-  Shameen. (2019, August 07). Researchers discover medication to silence HIV infection. Retrieved from https://www.siasat.com/researchers-discover-medication-silence-hiv-infection-1575020/
-  Liu, Z., Wang, P., Chen, H., Wold, E. A., Tian, B., Brasier, A. R., & Zhou, J. (2017). Drug discovery targeting bromodomain-containing protein 4. Journal of medicinal chemistry, 60(11), 4533-4558.